135 related articles for article (PubMed ID: 10934891)
1. [Treatment of pulmonary artery hypertension].
Olschewski H; Seeger W
Pneumologie; 2000 Jun; 54(6):222-4. PubMed ID: 10934891
[No Abstract] [Full Text] [Related]
2. Treatment of pulmonary arterial hypertension.
Humbert M; Sitbon O; Simonneau G
N Engl J Med; 2004 Sep; 351(14):1425-36. PubMed ID: 15459304
[No Abstract] [Full Text] [Related]
3. [Inhaled prostacyclin and iloprost in severe pulmonary hypertension secondary to pulmonary fibrosis].
Olschewski H; Ghofrani HA; Walmrath D; Schermuly R; Temmesfeld-Wollbrück B; Grimminger F; Seeger W
Pneumologie; 2000 Mar; 54(3):133-42. PubMed ID: 10783653
[TBL] [Abstract][Full Text] [Related]
4. [Therapy of severe pulmonary hypertension with prostacyclin and iloprost].
Matthes J; Mathen F; Herzig S; Wassermann K
Dtsch Med Wochenschr; 2001 May; 126(21):631-7. PubMed ID: 11413752
[No Abstract] [Full Text] [Related]
5. Successful transition from intravenous to inhaled prostacyclin in a patient with pulmonary hypertension and right ventricular failure.
Reddy MT; Patel H; Ventura HO
Congest Heart Fail; 2008; 14(5):285-6. PubMed ID: 18983294
[No Abstract] [Full Text] [Related]
6. [Current approach to the treatment of pulmonary arterial hypertension and our experience in the Cardiology Department of Medicine Faculty of Ege University].
Kayikçioğlu M; Kültürsay H
Turk Kardiyol Dern Ars; 2009 Dec; 37(8):580-90. PubMed ID: 20200464
[TBL] [Abstract][Full Text] [Related]
7. Inhaled prostacyclin, nitric oxide, and nitroprusside in pulmonary hypertension after mitral valve replacement.
Fattouch K; Sbraga F; Bianco G; Speziale G; Gucciardo M; Sampognaro R; Ruvolo G
J Card Surg; 2005; 20(2):171-6. PubMed ID: 15725144
[TBL] [Abstract][Full Text] [Related]
8. Twin pregnancy in a woman on long-term epoprostenol therapy for primary pulmonary hypertension. A case report.
Badalian SS; Silverman RK; Aubry RH; Longo J
J Reprod Med; 2000 Feb; 45(2):149-52. PubMed ID: 10710749
[TBL] [Abstract][Full Text] [Related]
9. Prostacyclin therapy for pulmonary arterial hypertension: new directions.
Gomberg-Maitland M; Preston IR
Semin Respir Crit Care Med; 2005 Aug; 26(4):394-401. PubMed ID: 16121316
[TBL] [Abstract][Full Text] [Related]
10. New therapeutic agents for pulmonary vascular disease.
Howard LS; Morrell NW
Paediatr Respir Rev; 2005 Dec; 6(4):285-91. PubMed ID: 16298312
[TBL] [Abstract][Full Text] [Related]
11. Epoprostenol (prostacyclin) therapy in primary pulmonary hypertension.
Botney M
N Engl J Med; 1998 Jun; 338(24):1773-4. PubMed ID: 9625639
[No Abstract] [Full Text] [Related]
12. High levels of nitric oxide in individuals with pulmonary hypertension receiving epoprostenol therapy.
Ozkan M; Dweik RA; Laskowski D; Arroliga AC; Erzurum SC
Lung; 2001; 179(4):233-43. PubMed ID: 11891614
[TBL] [Abstract][Full Text] [Related]
13. Timeline of haemodynamic improvement with subcutaneous prostacyclin therapy in a patient with severe pulmonary arterial hypertension.
Sadushi-Koliçi R; Perthold W; Fruhwald FM; Lang IM
Eur J Clin Invest; 2008 Aug; 38(8):603-4. PubMed ID: 18573098
[No Abstract] [Full Text] [Related]
14. Prostanoid therapy for pulmonary arterial hypertension.
Strauss WL; Edelman JD
Clin Chest Med; 2007 Mar; 28(1):127-42; ix. PubMed ID: 17338932
[TBL] [Abstract][Full Text] [Related]
15. Medical & surgical approaches to pulmonary hypertension.
McLaughlin VV; Rich S
Compr Ther; 1997 Sep; 23(9):612-6. PubMed ID: 9285162
[TBL] [Abstract][Full Text] [Related]
16. Epoprostenol and nitric oxide therapy for severe pulmonary hypertension in liver transplantation.
Molmenti EP; Ramsay M; Ramsay K; Lynch K; Tillmann Hein HA; Molmenti H; Levy M; Goldstein R; Ausloos K; East C; Fasola C; Jung G; Escobar J; Klintmalm G
Transplant Proc; 2001; 33(1-2):1332. PubMed ID: 11267313
[No Abstract] [Full Text] [Related]
17. Use of prostacyclin and its analogues in the treatment of cardiovascular disease.
Fink AN; Frishman WH; Azizad M; Agarwal Y
Heart Dis; 1999; 1(1):29-40. PubMed ID: 11720602
[TBL] [Abstract][Full Text] [Related]
18. Comparison between two drugs on the hemodynamic evaluation of pulmonary hypertension prior to heart transplantation.
Mogollón Jiménez MV; Escoresca Ortega AM; Hinojosa Pérez R; Lage Gallé E; Herruzo Avilés A; Sobrino Márquez M; Frutos López M; Romero Rodríguez N; Pérez de la Yglesia R; Martínez Martínez A
Transplant Proc; 2008 Nov; 40(9):3009-11. PubMed ID: 19010174
[TBL] [Abstract][Full Text] [Related]
19. The perioperative management of portopulmonary hypertension with nitric oxide and epoprostenol.
Ramsay MA; Spikes C; East CA; Lynch K; Hein HA; Ramsay KJ; Klintmalm GB
Anesthesiology; 1999 Jan; 90(1):299-301. PubMed ID: 9915339
[No Abstract] [Full Text] [Related]
20. Prostanoid therapy for pulmonary arterial hypertension.
Badesch DB; McLaughlin VV; Delcroix M; Vizza CD; Olschewski H; Sitbon O; Barst RJ
J Am Coll Cardiol; 2004 Jun; 43(12 Suppl S):56S-61S. PubMed ID: 15194179
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
